Asset Details
Do you wish to reserve the book?
Systemic outcomes of symptomatic peripheral artery disease patients with end-stage renal disease undergoing lower limb endovascular treatment: a propensity score-matched analysis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Systemic outcomes of symptomatic peripheral artery disease patients with end-stage renal disease undergoing lower limb endovascular treatment: a propensity score-matched analysis
Do you wish to request the book?
Systemic outcomes of symptomatic peripheral artery disease patients with end-stage renal disease undergoing lower limb endovascular treatment: a propensity score-matched analysis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Systemic outcomes of symptomatic peripheral artery disease patients with end-stage renal disease undergoing lower limb endovascular treatment: a propensity score-matched analysis
2025
Overview
Background
This study investigates the impact of end-stage renal disease (ESRD) on systemic and localized outcomes in peripheral artery disease (PAD) patients following endovascular therapy (EVT), with a focus on major adverse cardiac and cerebrovascular events (MACCEs).
Methods
This retrospective cohort study included symptomatic PAD patients, categorized by the Rutherford classification, who underwent EVT at a single tertiary medical center from May 2018 to May 2021. Patients were divided into ESRD and non-ESRD groups. A propensity score-matched (PSM) analysis was performed to minimize confounding factors. The primary outcome was the occurrence of MACCEs, while the secondary outcome was the incidence of major adverse limb events (MALEs).
Results
ESRD patients exhibited significantly worse systemic outcomes, with higher MACCE rates compared to non-ESRD patients in both the entire cohort (79.9% vs. 39.9%; HR: 2.69; 95% CI: 1.80–4.02;
p
< 0.001) and the matched cohort (HR: 3.88; 95% CI: 2.30–6.53;
p
< 0.001). They also had higher rates of all-cause mortality and myocardial infarction (MI). For localized outcomes, MALEs were more frequent in the ESRD group in the entire cohort (61.0% vs. 34.9%; HR: 1.84; 95% CI: 1.22–2.76;
p
< 0.001), but no significant difference was observed in the matched cohort (HR: 1.23; 95% CI: 0.76–1.99;
p
= 0.40). ESRD was identified as the sole independent predictor of increased MACCE risk (HR: 2.49; 95% CI: 1.65–3.75;
p
< 0.001).
Conclusions
PAD patients with ESRD face significantly worse systemic outcomes, particularly elevated MACCE rates, after EVT. Preventing MACCEs, especially MI, is essential in this high-risk population. Despite more severe limb conditions, ESRD alone did not significantly increase MALE risk after PSM.
Clinical trial number
Not applicable.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Complications and side effects
/ Endovascular Procedures - adverse effects
/ Endovascular Procedures - mortality
/ Female
/ Humans
/ Ischemia
/ Kidney Failure, Chronic - diagnosis
/ Kidney Failure, Chronic - mortality
/ Kidney Failure, Chronic - therapy
/ Lower Extremity - blood supply
/ MACCEs
/ Male
/ MALEs
/ Medicine
/ Patients
/ Peripheral Arterial Disease - diagnosis
/ Peripheral Arterial Disease - diagnostic imaging
/ Peripheral Arterial Disease - mortality
/ Peripheral Arterial Disease - therapy
/ Peripheral vascular diseases
/ Surgeons
